TScan Therapeutics CEO David Southwell's 2022 pay falls 24% to $2.1M
TScan Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 25, 2023
TScan Therapeutics reported fiscal year 2022 executive compensation information on April 25, 2023.
In 2022, three executives at TScan Therapeutics received on average a compensation package of $1.7M, a 29% decrease compared to previous year.
Average pay of disclosed executives at TScan Therapeutics
David Southwell, Chief Executive Officer, received $2.1M in total, which decreased by 24% compared to 2021. 55% of Southwell's compensation, or $1.2M, was in option awards. Southwell also received $342K in non-equity incentive plan, $622K in salary, as well as $8.9K in other compensation.
Brian Silver, Chief Financial Officer, received a compensation package of $1.6M, which decreased by 50% compared to previous year. 57% of the compensation package, or $911K, was in option awards.
Gavin MacBeath, Chief Executive Officer, earned $1.4M in 2022, a 14% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 25, 2023.